Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 1.89 | 1.97 | 0.08 |
Stocks | 98.10 | 98.10 | 0.00 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 22.92 | 21.90 |
Price to Book | 5.22 | 4.03 |
Price to Sales | 2.33 | 2.28 |
Price to Cash Flow | 19.60 | 17.07 |
Dividend Yield | 1.20 | 1.34 |
5 Years Earnings Growth | 11.94 | 11.27 |
Number of long holdings: 50
Number of short holdings: 4
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 9.05 | 752.13 | -1.03% | |
UnitedHealth | US91324P1021 | 7.27 | 510.04 | -0.54% | |
Novo Nordisk B | DK0062498333 | 7.11 | 909.9 | +3.02% | |
Merck&Co | US58933Y1055 | 5.69 | 128.43 | -1.26% | |
Thermo Fisher Scientific | US8835561023 | 4.51 | 591.46 | -0.27% | |
AstraZeneca | GB0009895292 | 3.68 | 12,294.0 | -0.61% | |
Abbott Labs | US0028241000 | 3.66 | 104.98 | +0.23% | |
Roche Holding Participation | CH0012032048 | 2.84 | 228.10 | +1.33% | |
Sanofi | FR0000120578 | 2.82 | 93.16 | +2.86% | |
Boston Scientific | US1011371077 | 2.70 | 72.70 | -1.34% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
AXA Framlington Global Technology a | 1.3B | 5.85 | 7.83 | 19.37 | ||
AXA Framlington Global Technology F | 1.3B | 5.85 | 7.83 | 19.36 | ||
GB00B5LXGG05 | 1.12B | 9.93 | 12.94 | 16.96 | ||
AXA Framlington UK Mid Cap Z Acc | 325.66M | 4.46 | -3.72 | 5.28 | ||
AXA Framlington UK Mid Cap Z Inc | 325.66M | 4.46 | -3.72 | 5.30 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review